1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow NTLA-2001: new trials by email Literature Review of NTLA-2001 trials Research Report on NTLA-2001
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NTLA-2001 in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy (ATTRv-PN) and Patients With Transthyretin Amyloidosis-Related Cardiomyopathy (ATTR-CM) NTLA-2001 - Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy, Transthyretin-Related (ATTR) Familial Amyloid Cardiomyopathy | Phase 1 | Completed | Intellia Therapeutics | 72 | 2020-11-05 | 2026-01-30 |
Amyloid Neuropathies, Familial (1) · Amyloidosis (1) · Cardiomyopathies (1) · Polyneuropathies (1)
France (1) · New Zealand (1) · Sweden (1) · United Kingdom (1)